Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.36%1.32B | 3.34%1.32B | 8.04%1.27B | 7.63%1.18B | -9.60%1.1B | -5.39%1.21B | -3.61%1.28B | 2.12%1.33B | -1.83%1.3B | 59.56%1.33B |
| Operating revenue | 0.36%1.32B | 3.34%1.32B | 8.04%1.27B | 7.63%1.18B | -9.60%1.1B | -5.39%1.21B | -3.61%1.28B | 2.12%1.33B | -1.83%1.3B | 59.56%1.33B |
| Cost of revenue | -0.24%376.9M | 8.04%377.8M | 7.47%349.7M | -7.79%325.4M | 13.29%352.9M | -12.08%311.5M | 3.42%354.3M | 3.13%342.6M | 3.91%332.2M | 43.49%319.7M |
| Gross profit | 0.60%945M | 1.57%939.4M | 8.25%924.9M | 14.95%854.4M | -17.51%743.3M | -2.84%901.1M | -6.05%927.4M | 1.77%987.1M | -3.66%969.9M | 65.44%1.01B |
| Operating expense | 0.62%178.9M | 26.46%177.8M | -25.73%140.6M | 33.97%189.3M | -79.94%141.3M | 411.62%704.5M | -0.86%137.7M | 5.47%138.9M | -11.31%131.7M | 27.47%148.5M |
| Selling and administrative expenses | -0.26%115.6M | 4.79%115.9M | 4.93%110.6M | --105.4M | ---- | -34.24%62.8M | -2.15%95.5M | -1.11%97.6M | -7.67%98.7M | 38.11%106.9M |
| -General and administrative expense | -0.26%115.6M | 4.79%115.9M | 4.93%110.6M | --105.4M | ---- | -34.24%62.8M | -2.15%95.5M | -1.11%97.6M | -7.67%98.7M | 38.11%106.9M |
| Depreciation amortization depletion | -6.67%4.2M | -8.16%4.5M | -10.91%4.9M | --5.5M | ---- | 11,605.41%433.1M | -17.78%3.7M | --4.5M | ---- | ---- |
| -Depreciation and amortization | -6.67%4.2M | -8.16%4.5M | -10.91%4.9M | --5.5M | ---- | 11,605.41%433.1M | -17.78%3.7M | --4.5M | ---- | ---- |
| Provision for doubtful accounts | ---- | 99.07%-200K | -256.93%-21.5M | -84.43%13.7M | --88M | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | 2.60%59.1M | 23.61%57.6M | -27.98%46.6M | 21.39%64.7M | -74.45%53.3M | 441.82%208.6M | 4.62%38.5M | 11.52%36.8M | -20.67%33M | 16.20%41.6M |
| Operating profit | 0.59%766.1M | -2.89%761.6M | 17.92%784.3M | 10.48%665.1M | 206.21%602M | -75.10%196.6M | -6.90%789.7M | 1.19%848.2M | -2.33%838.2M | 74.43%858.2M |
| Net non-operating interest income (expenses) | -8.78%-225.6M | -4.80%-207.4M | -6.97%-197.9M | -24.58%-185M | 20.38%-148.5M | -1.69%-186.5M | -3.67%-183.4M | -21.58%-176.9M | 8.89%-145.5M | -10.14%-159.7M |
| Non-operating interest income | -9.89%8.2M | 33.82%9.1M | 161.54%6.8M | -82.55%2.6M | 302.70%14.9M | -22.92%3.7M | -14.29%4.8M | -40.43%5.6M | -38.96%9.4M | 201.96%15.4M |
| Non-operating interest expense | 8.97%204.1M | 6.54%187.3M | 10.57%175.8M | 14.64%159M | -18.22%138.7M | -8.37%169.6M | 2.89%185.1M | 16.14%179.9M | -11.54%154.9M | 16.66%175.1M |
| Total other finance cost | 1.71%29.7M | 1.04%29.2M | 1.05%28.9M | 15.79%28.6M | 19.90%24.7M | 564.52%20.6M | 19.23%3.1M | --2.6M | ---- | ---- |
| Other net income (expenses) | 4,688.00%458.8M | 96.88%-10M | -144.03%-320.3M | 202.38%727.5M | 60.50%-710.6M | -591.39%-1.8B | -147.53%-260.2M | -38.56%547.4M | 239.52%890.9M | -21.22%262.4M |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.99%-3M | ---298.3M |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.99%3M | --298.3M |
| Other non-operating income (expenses) | 9,420.93%409.4M | 101.60%4.3M | -137.86%-269.4M | 205.20%711.6M | 59.62%-676.4M | -499.89%-1.67B | -153.63%-279.2M | -40.55%520.6M | 54.53%875.7M | 74.15%566.7M |
| Income before tax | 83.63%999.3M | 104.51%544.2M | -77.96%266.1M | 588.71%1.21B | 86.19%-247.1M | -616.87%-1.79B | -71.60%346.1M | -23.04%1.22B | 64.80%1.58B | 41.29%960.9M |
| Income tax | -82.76%-5.3M | 46.30%-2.9M | 28.95%-5.4M | -169.72%-7.6M | -9.92%10.9M | 12.1M | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 83.62%1B | 101.51%547.1M | -77.66%271.5M | 571.01%1.22B | 85.67%-258M | -620.37%-1.8B | -71.60%346.1M | -23.04%1.22B | 64.80%1.58B | 42.33%960.9M |
| Net income continuous operations | 83.62%1B | 101.51%547.1M | -77.66%271.5M | 571.01%1.22B | 85.67%-258M | -620.37%-1.8B | -71.60%346.1M | -23.04%1.22B | 64.80%1.58B | 42.33%960.9M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 83.62%1B | 101.51%547.1M | -77.66%271.5M | 571.01%1.22B | 85.67%-258M | -620.37%-1.8B | -71.60%346.1M | -23.04%1.22B | 64.80%1.58B | 42.33%960.9M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 83.62%1B | 101.51%547.1M | -77.66%271.5M | 571.01%1.22B | 85.67%-258M | -620.37%-1.8B | -71.60%346.1M | -23.04%1.22B | 64.80%1.58B | 42.33%960.9M |
| Diluted earnings per share | 83.44%0.2205 | 101.68%0.1202 | -77.67%0.0596 | 570.72%0.2669 | 88.01%-0.0567 | -623.23%-0.473 | -71.13%0.0904 | -21.73%0.3131 | 64.81%0.4 | -5.05%0.2427 |
| Basic earnings per share | 83.40%0.2199 | 101.51%0.1199 | -77.67%0.0595 | 569.84%0.2664 | 88.01%-0.0567 | -624.39%-0.473 | -71.14%0.0902 | -21.78%0.3125 | 64.74%0.3995 | -3.81%0.2425 |
| Dividend per share | -2.07%0.1185 | 5.68%0.121 | 143.62%0.1145 | -53.00%0.047 | 29.87%0.1 | -51.57%0.077 | -2.45%0.159 | -5.78%0.163 | -2.26%0.173 | 4.73%0.177 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |